Average Co-Inventor Count = 6.35
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (35 from 2,076 patents)
2. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
36 patents:
1. 12134636 - Immunoglobulins and uses thereof
2. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
3. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
4. 11732019 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
5. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
6. 11401315 - Immunoglobulins and uses thereof
7. 11098016 - Indazole derivatives useful as glucagon receptor antagonists
8. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
9. 10968264 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
10. 10961293 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
11. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
12. 10858413 - Immunoglobulins and uses thereof
13. 10787495 - Immunoglobulins and uses thereof
14. 10774048 - Indazole derivatives useful as glucagon receptor antagonists
15. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors